{"id":468,"date":"2020-07-06T15:57:31","date_gmt":"2020-07-06T15:57:31","guid":{"rendered":"https:\/\/ramonalfonso.es\/?p=468"},"modified":"2021-09-21T11:14:28","modified_gmt":"2021-09-21T11:14:28","slug":"informe-dexcom-julio-2020","status":"publish","type":"post","link":"https:\/\/www.norzpatrimonia.com\/blog\/informe-dexcom-julio-2020\/","title":{"rendered":"INFORME DEXCOM – JULIO 2020"},"content":{"rendered":"\n

DexCom <\/b>es una compa\u00f1\u00eda de dispositivos m\u00e9dicos que se enfoca en el dise\u00f1o, desarrollo y comercializaci\u00f3n de sistemas de monitoreo continuo de glucosa (CGM) en los Estados Unidos e internacionalmente. La compa\u00f1\u00eda es reconocida por la alta calidad de sus dispositivos. Hay pron\u00f3sticos de la OMS que indican que la diabetes ser\u00e1 la s\u00e9ptima causa principal de muerte en la poblaci\u00f3n mundial para 2030, con un crecimiento estimado de m\u00e1s del 12% para 2025.<\/span><\/p>\n

\u00a0<\/span><\/p>\n

DexCom <\/b>is a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company is recognized for the high quality of its devices. There are forecasts by the WHO that indicate that diabetes will be the seventh leading cause of death in the world population by 2030, with an estimated growth over 12% is expected for 2025.<\/span><\/p>\n

 <\/p>\n

DEXCOM ANALYSIS 2 JUL 2020<\/a><\/div>\n

 <\/p>\n\n\n\n\n\n

Descargar<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

DexCom es una compa\u00f1\u00eda de dispositivos m\u00e9dicos que se enfoca en el dise\u00f1o, desarrollo y comercializaci\u00f3n de sistemas de monitoreo continuo de glucosa (CGM) en los Estados Unidos e internacionalmente. La compa\u00f1\u00eda es reconocida por la alta calidad de sus dispositivos. Hay pron\u00f3sticos de la OMS que indican que la diabetes ser\u00e1 la s\u00e9ptima causa […]<\/p>\n","protected":false},"author":3,"featured_media":477,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"episode_type":"","audio_file":"","podmotor_file_id":"","podmotor_episode_id":"","cover_image":"","cover_image_id":"","duration":"","filesize":"","filesize_raw":"","date_recorded":"","explicit":"","block":"","footnotes":""},"categories":[233],"tags":[],"series":[],"class_list":["post-468","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analisis"],"episode_featured_image":"https:\/\/www.norzpatrimonia.com\/blog\/wp-content\/uploads\/2020\/07\/informe-dexcom.jpg","episode_player_image":"https:\/\/www.norzpatrimonia.com\/blog\/wp-content\/uploads\/2022\/02\/blog-inversion.jpg","download_link":"","player_link":"","audio_player":false,"episode_data":{"playerMode":"light","subscribeUrls":{"apple_podcasts":{"key":"apple_podcasts","url":"","label":"Apple Podcasts","class":"apple_podcasts","icon":"apple-podcasts.png"},"stitcher":{"key":"stitcher","url":"","label":"Stitcher","class":"stitcher","icon":"stitcher.png"},"google_podcasts":{"key":"google_podcasts","url":"https:\/\/www.google.com\/podcasts?feed=aHR0cHM6Ly93d3cuYmxvZ2ludmVyc2lvbi5jb20vZmVlZC9wb2RjYXN0","label":"Google Podcasts","class":"google_podcasts","icon":"google-podcasts.png"},"spotify":{"key":"spotify","url":"https:\/\/open.spotify.com\/show\/1Vji4f6SYTHZ0OZC3w5ydB","label":"Spotify","class":"spotify","icon":"spotify.png"}},"rssFeedUrl":"https:\/\/www.norzpatrimonia.com\/blog\/feed\/podcast\/blog-inversion","embedCode":"

INFORME DEXCOM – JULIO 2020<\/a><\/blockquote>